Amgen Gets FDA Nod for Arthritis Drug Dosage
Amgen(AMGN Quote) and Wyeth Pharmaceuticals said Monday that the Food and Drug Administration has approved a once-weekly dosage of the arthritis drug Enbrel.
Enbrel is approved to treat moderate to severe active rheumatoid arthritis in patients with psoriatic arthritis and active ankylosing spondylitis, the company said. Wyeth Pharmaceuticals is a division of Wyeth(WYE Quote).- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,344.84 | 1,095.63 | 2,144.60 | 32.01 |
Oil *
78.55
|
|
UP
34.92
|
UP
4.14
|
UP
6.16
|
DOWN
0.30
|
10 Yr
3.20%
SPDR Gold
115.65
|
|
+0.34%
|
+0.38%
|
+0.29%
|
-0.93%
|
Data delayed 20 minutes |
